Since a 2016 analysis on the epidemiology and disease burden of HCV in Croatia, the HCV treatment paradigm has shifted substantially. Fibrosis restrictions were removed, and the number of patients treated tripled. With these encouraging changes to policy and practice, an updated analysis was completed to guide resource allocation and a national strategic plan for HCV elimination in Croatia. A comprehensive literature review and discussions with in-country experts were used to identify epidemiological factors defining HCV disease burden in Croatia. An HCV disease burden model, seeded with this data, was used to assess the impact of increasing screening rates and delineate the steps needed to reach the World Health Organization’s (WHO) Global...
The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population age...
Background: Novel direct antiviral agents (DAAs) will become available soon with higher sustained vi...
The public health impact of hepatitis C virus (HCV) infection has been realized only recently. Globa...
Since a 2016 analysis on the epidemiology and disease burden of HCV in Croatia, the HCV treatment pa...
Background: Since a 2016 analysis on the epidemiology and disease burden of HCV in Croatia, the HCV ...
BACKGROUND:In 2016, the World Health Organization (WHO) and 69th World Health Assembly approved the ...
Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality world...
The majority of people infected with chronic hepatitis C virus (HCV) in the European Union (EU) rema...
Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality world...
In 2016, the WHO announced a plan to eliminate viral hepatitis as a public health threat by 2030. In...
The number of hepatitis C virus (HCV) infections is projected to decline while those with advanced l...
Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In th...
Background : The World Health Organization (WHO) released updated guidelines for the screening, care...
The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population age...
Background: Novel direct antiviral agents (DAAs) will become available soon with higher sustained vi...
The public health impact of hepatitis C virus (HCV) infection has been realized only recently. Globa...
Since a 2016 analysis on the epidemiology and disease burden of HCV in Croatia, the HCV treatment pa...
Background: Since a 2016 analysis on the epidemiology and disease burden of HCV in Croatia, the HCV ...
BACKGROUND:In 2016, the World Health Organization (WHO) and 69th World Health Assembly approved the ...
Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality world...
The majority of people infected with chronic hepatitis C virus (HCV) in the European Union (EU) rema...
Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality world...
In 2016, the WHO announced a plan to eliminate viral hepatitis as a public health threat by 2030. In...
The number of hepatitis C virus (HCV) infections is projected to decline while those with advanced l...
Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In th...
Background : The World Health Organization (WHO) released updated guidelines for the screening, care...
The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population age...
Background: Novel direct antiviral agents (DAAs) will become available soon with higher sustained vi...
The public health impact of hepatitis C virus (HCV) infection has been realized only recently. Globa...